Skip to main content
. 2020 Nov 11;21(22):8467. doi: 10.3390/ijms21228467

Figure 7.

Figure 7

FASN is not a direct c-MYC target in mouse and human HCC cell lines. (A) Effect of c-Myc silencing on the protein (upper panel) and mRNA levels of c-Myc (middle panel) and Fasn (lower panel) in the HCC3-4 mouse HCC cell line. (B) Effect of c-Myc silencing on the protein (upper panel) and mRNA levels of c-Myc (middle panel) and Fasn (lower panel) in the HCC4-4 mouse HCC cell line. (C) Effect of c-MYC silencing on the protein (upper panel) and mRNA levels of c-MYC (middle panel) and FASN (lower panel) in the SNU475 human HCC cell line. Tukey–Kramer test: at least p < 0.01; a, vs. control (untreated); b, vs. Scramble (solvent).